Jeffrey S. Glenn

Insider Reports History

Entity
Individual
Location
350 Cambridge Avenue, Suite 350, Palo Alto, CA
Signature
/s/ Jeffrey S. Glenn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey S. Glenn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. Director Common Stock 182K $54.3K $0.30 Dec 22, 2022 Direct
Eiger BioPharmaceuticals, Inc. Director Common Stock 151K $45K $0.30 Dec 22, 2022 By Eiger Group International, Inc.
Eiger BioPharmaceuticals, Inc. Director Common Stock 5K $1.49K $0.30 Dec 22, 2022 By spouse
Eiger BioPharmaceuticals, Inc. Director Common Stock 460 $137 $0.30 Dec 22, 2022 By son
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 28K Mar 1, 2023 Direct

Insider Reports Filed by Jeffrey S. Glenn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EIGR Eiger BioPharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
EIGR Eiger BioPharmaceuticals, Inc. Dec 22, 2022 1 $128K 4 Dec 27, 2022 Director
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Director